New Key Statistics Module, Z-Score and F-Score
OTCPK:HTSUF Key Ratios
| Market Cap $ M | 1,678.36 |
| Enterprise Value $ M | 903.16 |
| P/E(ttm) | 20.04 |
| PE Ratio without NRI | 19.49 |
| Forward PE Ratio | -- |
| Price/Book | 1.04 |
| Price/Sales | 1.97 |
| Price/Free Cash Flow | 54.34 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.45 |
| Revenue (TTM) $ M | 974.00 |
| EPS (TTM) $ | 1.26 |
| Beneish M-Score | -2.4 |
| 10-y EBITDA Growth Rate % | -6.90 |
| 5-y EBITDA Growth Rate % | -5.00 |
| y-y EBITDA Growth Rate % | 19.20 |
| EV-to-EBIT | 7.48 |
| EV-to-EBITDA | 7.48 |
| PEG | -- |
| Shares Outstanding M | 73.37 |
| Net Margin (%) | 9.86 |
| Operating Margin % | 9.29 |
| Pre-tax Margin (%) | 13.54 |
| Quick Ratio | 3.76 |
| Current Ratio | 4.22 |
| ROA % (ttm) | 4.25 |
| ROE % (ttm) | 5.28 |
| ROIC % (ttm) | 5.46 |
| Dividend Yield % | 2.26 |
| Altman Z-Score | 4.79 |
HTSUF Number of Guru Trades
HTSUF Volume of Guru Trades
Gurus Latest Trades with OTCPK:HTSUF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:HTSUF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hisamitsu Pharmaceutical Co Inc Insider Transactions
No Available Data
News about OTCPK:HTSUF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers